Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant

BACKGROUND:  The national stockpile for influenza pandemic preparedness includes vaccines against an array of strains and adjuvants that could be utilized to induce immunologic priming as a pandemic wave emerges. We assessed the feasibility of a strategy that allows the flexibility of postmanufactur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wilbur H., Jackson, Lisa A., Edwards, Kathryn M., Keitel, Wendy A., Hill, Heather, Noah, Diana L., Creech, C. Buddy, Patel, Shital M., Mangal, Brian, Kotloff, Karen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324222/
https://www.ncbi.nlm.nih.gov/pubmed/25734159
http://dx.doi.org/10.1093/ofid/ofu091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324222/
https://www.ncbi.nlm.nih.gov/pubmed/25734159
http://dx.doi.org/10.1093/ofid/ofu091

Ejemplares similares